Bionano Cash vs Other Liab Analysis

BNGO Stock  USD 0.20  0.01  4.76%   
Bionano Genomics financial indicator trend analysis is way more than just evaluating Bionano Genomics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bionano Genomics is a good investment. Please check the relationship between Bionano Genomics Cash and its Other Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bionano Genomics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
To learn how to invest in Bionano Stock, please use our How to Invest in Bionano Genomics guide.

Cash vs Other Liab

Cash vs Other Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Bionano Genomics Cash account and Other Liab. At this time, the significance of the direction appears to have very week relationship.
The correlation between Bionano Genomics' Cash and Other Liab is 0.2. Overlapping area represents the amount of variation of Cash that can explain the historical movement of Other Liab in the same time period over historical financial statements of Bionano Genomics, assuming nothing else is changed. The correlation between historical values of Bionano Genomics' Cash and Other Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash of Bionano Genomics are associated (or correlated) with its Other Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Liab has no effect on the direction of Cash i.e., Bionano Genomics' Cash and Other Liab go up and down completely randomly.

Correlation Coefficient

0.2
Relationship DirectionPositive 
Relationship StrengthVery Weak

Cash

Cash refers to the most liquid asset of Bionano Genomics, which is listed under current asset account on Bionano Genomics balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Bionano Genomics customers. The amounts must be unrestricted with restricted cash listed in a different Bionano Genomics account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.

Other Liab

Most indicators from Bionano Genomics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bionano Genomics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bionano Genomics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
To learn how to invest in Bionano Stock, please use our How to Invest in Bionano Genomics guide.At this time, Bionano Genomics' Tax Provision is very stable compared to the past year. As of the 25th of December 2024, Selling General Administrative is likely to grow to about 98.2 M, while Enterprise Value Over EBITDA is likely to drop (0.62).
 2021 2022 2023 2024 (projected)
Interest Expense927K298K5.1M5.4M
Depreciation And Amortization4.0M10.1M13.7M14.4M

Bionano Genomics fundamental ratios Correlations

0.330.630.470.980.790.950.80.840.22-0.670.940.360.950.010.720.960.670.850.860.72-0.350.860.80.820.17
0.330.40.930.240.730.540.740.40.84-0.890.480.480.290.50.550.290.660.760.750.55-0.430.750.650.740.15
0.630.40.580.50.770.510.780.860.54-0.680.76-0.160.770.540.390.420.560.640.690.390.130.670.820.760.4
0.470.930.580.360.880.640.870.540.94-0.950.620.230.470.590.530.390.750.790.830.53-0.350.840.80.840.22
0.980.240.50.360.710.920.720.770.08-0.580.890.410.92-0.120.690.960.590.790.790.69-0.40.80.730.740.1
0.790.730.770.880.710.861.00.820.75-0.950.870.20.810.510.590.680.770.920.970.59-0.30.970.960.980.19
0.950.540.510.640.920.860.860.760.39-0.780.880.480.850.130.720.950.690.910.920.72-0.460.930.80.860.13
0.80.740.780.870.721.00.860.830.73-0.950.880.240.820.490.620.70.760.940.980.62-0.30.970.970.990.24
0.840.40.860.540.770.820.760.830.4-0.70.860.130.890.320.550.710.590.770.810.55-0.190.790.850.830.37
0.220.840.540.940.080.750.390.730.4-0.810.39-0.060.260.770.230.120.590.550.630.23-0.130.630.650.660.2
-0.67-0.89-0.68-0.95-0.58-0.95-0.78-0.95-0.7-0.81-0.8-0.37-0.68-0.47-0.69-0.57-0.83-0.93-0.95-0.690.43-0.95-0.91-0.96-0.16
0.940.480.760.620.890.870.880.880.860.39-0.80.310.960.10.810.830.830.890.90.81-0.380.910.910.90.19
0.360.48-0.160.230.410.20.480.240.13-0.06-0.370.310.19-0.370.690.460.350.540.420.69-0.70.420.180.33-0.11
0.950.290.770.470.920.810.850.820.890.26-0.680.960.190.080.670.830.670.820.840.67-0.270.840.880.850.2
0.010.50.540.59-0.120.510.130.490.320.77-0.470.1-0.370.08-0.28-0.070.070.250.35-0.280.410.310.380.380.18
0.720.550.390.530.690.590.720.620.550.23-0.690.810.690.67-0.280.680.850.790.721.0-0.70.750.650.70.11
0.960.290.420.390.960.680.950.70.710.12-0.570.830.460.83-0.070.680.560.780.780.68-0.370.780.640.690.14
0.670.660.560.750.590.770.690.760.590.59-0.830.830.350.670.070.850.560.760.770.85-0.630.820.790.8-0.04
0.850.760.640.790.790.920.910.940.770.55-0.930.890.540.820.250.790.780.760.990.79-0.460.980.910.960.21
0.860.750.690.830.790.970.920.980.810.63-0.950.90.420.840.350.720.780.770.990.72-0.40.990.940.980.22
0.720.550.390.530.690.590.720.620.550.23-0.690.810.690.67-0.281.00.680.850.790.72-0.70.750.650.70.11
-0.35-0.430.13-0.35-0.4-0.3-0.46-0.3-0.19-0.130.43-0.38-0.7-0.270.41-0.7-0.37-0.63-0.46-0.4-0.7-0.47-0.33-0.40.33
0.860.750.670.840.80.970.930.970.790.63-0.950.910.420.840.310.750.780.820.980.990.75-0.470.940.980.15
0.80.650.820.80.730.960.80.970.850.65-0.910.910.180.880.380.650.640.790.910.940.65-0.330.940.980.22
0.820.740.760.840.740.980.860.990.830.66-0.960.90.330.850.380.70.690.80.960.980.7-0.40.980.980.2
0.170.150.40.220.10.190.130.240.370.2-0.160.19-0.110.20.180.110.14-0.040.210.220.110.330.150.220.2
Click cells to compare fundamentals

Bionano Genomics Account Relationship Matchups

Bionano Genomics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets30.2M60.4M377.1M307.5M214.4M142.9M
Short Long Term Debt Total20.0M36.4M10.7M11.7M79.4M83.4M
Other Current Liab3.2M5.6M7.9M17.4M16.3M9.4M
Total Current Liabilities26.3M8.9M21.8M35.9M100.0M105.0M
Total Stockholder Equity3.6M35.1M337.1M249.4M96.2M89.9M
Other Liab227.1K97.9K9.2M13.1M15.1M15.8M
Net Tangible Assets3.6M26.4M337.1M172.1M197.9M207.8M
Property Plant And Equipment Net1.9M4.9M20.9M29.0M32.5M34.1M
Current Deferred Revenue357.5K415.5K684K871K783K555.6K
Net Debt2.7M(22.1M)(13.9M)6.6M61.5M64.5M
Retained Earnings(102.6M)(143.7M)(216.1M)(348.7M)(581.2M)(552.1M)
Accounts Payable2.7M2.9M9.7M12.5M10.4M5.9M
Cash17.3M38.4M24.6M5.1M17.9M17.3M
Non Current Assets Total1.9M13.7M104.7M150.2M74.3M48.6M
Non Currrent Assets Other(1.9M)102.6K749K2.8M7.4M7.8M
Cash And Short Term Investments17.3M38.4M250.6M113.2M101.9M74.8M
Net Receivables6.3M2.8M4.9M7.0M9.7M5.6M
Common Stock Total Equity3.4K19.0K29K30K34.5K36.2K
Common Stock Shares Outstanding1.5M10.4M27.7M28.9M34.2M35.9M
Liabilities And Stockholders Equity30.3M60.4M377.1M307.5M214.4M142.9M
Non Current Liabilities Total335.0K16.4M18.1M22.2M18.2M16.2M
Capital Surpluse106.2M178.7M553.7M599.2M689.1M723.5M
Inventory3.4M3.3M12.4M29.8M22.9M24.0M
Other Current Assets1.2M2.2M4.5M7.3M7.1M7.5M
Other Stockholder Equity106.2M178.7M553.7M599.2M677.3M711.2M
Total Liab26.6M25.4M40.0M58.1M118.2M124.2M
Property Plant And Equipment Gross1.9M4.9M10.3M29.0M51.6M54.1M
Total Current Assets28.3M46.8M272.4M157.3M140.1M94.3M
Non Current Liabilities Other808.4K44.5K18.0M22.1M10.9M8.4M
Common Stock3.4K19.0K29K30K5K4.8K
Property Plant Equipment1.9M4.9M10.3M18.0M20.7M21.8M
Net Invested Capital23.7M51.4M337.1M249.4M166.0M126.2M
Net Working Capital1.9M37.8M250.6M121.4M40.1M72.4M
Retained Earnings Total Equity(102.6M)(143.7M)(216.1M)(348.7M)(313.8M)(298.2M)
Deferred Long Term Liab182.6K97.9K146K127K114.3K137.3K

Pair Trading with Bionano Genomics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bionano Genomics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionano Genomics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bionano Stock

  0.62A Agilent TechnologiesPairCorr
  0.94ME 23Andme HoldingPairCorr
  0.8VALN Valneva SE ADRPairCorr

Moving against Bionano Stock

  0.84VCEL Vericel Corp OrdPairCorr
  0.78VCYT VeracytePairCorr
  0.78DRUG Bright Minds BiosciencesPairCorr
  0.75SABSW SAB BiotherapeuticsPairCorr
  0.7DSGN Design TherapeuticsPairCorr
The ability to find closely correlated positions to Bionano Genomics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bionano Genomics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bionano Genomics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bionano Genomics to buy it.
The correlation of Bionano Genomics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bionano Genomics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bionano Genomics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bionano Genomics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Bionano Genomics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bionano Genomics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bionano Genomics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bionano Genomics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bionano Genomics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
To learn how to invest in Bionano Stock, please use our How to Invest in Bionano Genomics guide.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bionano Genomics. If investors know Bionano will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bionano Genomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.30)
Revenue Per Share
0.749
Quarterly Revenue Growth
(0.10)
Return On Assets
(0.33)
Return On Equity
(1.38)
The market value of Bionano Genomics is measured differently than its book value, which is the value of Bionano that is recorded on the company's balance sheet. Investors also form their own opinion of Bionano Genomics' value that differs from its market value or its book value, called intrinsic value, which is Bionano Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bionano Genomics' market value can be influenced by many factors that don't directly affect Bionano Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bionano Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bionano Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bionano Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.